New med-tech firm Camcon Medical launches in the UK

Charlotte Edwards 19 November 2018 (Last Updated November 19th, 2018 15:00)

A new medical technology company called Camcon Medical has launched in the UK today. The company specialises in the precise, high-speed and low-energy control of liquid and gas for the healthcare industry and plans to promote its unique Binary Actuation Technology (BAT).

New med-tech firm Camcon Medical launches in the UK
The Intelligent Medical Oxygen Delivery system (IMOD) is one of Camcon Medical’s first ventures into respiratory care and another general oxygen image Credit: Camcon Medical.

A new medical technology company called Camcon Medical has launched in the UK today. The company specialises in the precise, high-speed and low-energy control of liquid and gas for the healthcare industry and plans to promote its unique Binary Actuation Technology (BAT).

Camcon Medical believes BAT could optimise the controlled flow of any fluid in a clinical or laboratory environment. The company aims to introduce BAT to areas of unmet medical need and where the valve could enhance the performance of existing devices. It could also be used to create new devices which require fluid control.

The company intends to focus on respiratory care in particular, with an initial focus on the medical devices market. One of its first applications will involve oxygen delivery and addressing common issues regarding accurate dosing, which can be fatal. An estimated 2,000 to 4,000 UK patients die every year from incorrect oxygen supply so the company believes its devices could be both lifesaving and cost-effective.

“Patient safety and quality of life are key for people who require oxygen therapy, whether within the home or clinical environment, which is where BAT can provide substantial benefits,” said Camcon Medical director Charles Potter. “The accurate dosage provided through our intelligent and silent valve technology can also reduce wastage, providing greater cost efficiencies, which is extremely important, as currently £34million is spent each year in the UK on wasted oxygen.

“We believe that with our technology we can deliver true innovation within this market, demonstrating the three dimensions of value that are critical in healthcare, including clinical benefit, patient quality of life and economic value.”

Camcon Medical director and BAT inventor Wladyslaw Wygnanski said: “The secret to BAT’s years of success is its versatility. While our initial efforts are focused on medical devices, this is just the beginning for us. We are also looking at opportunities within three additional areas where BAT can be applied. These include implantable devices within the human body, mechanical aids, such as prosthetics and blood circulation support and accurate laboratory dispensing equipment, which can also be applied to drug dosing and delivery.”

Wygnanski invented BAT in 1998 to enable valves to switch between open and closed status faster than other valve mechanisms, while using a very small amount of energy. Since then BAT has aided breakthroughs in various industry challenges and markets. Camcon’s move into healthcare and life sciences is due to BAT’s success in the oil and gas and automatic industries.

He added: “We are reviewing the opportunities within these markets and are keen to invite potential partners to collaborate with us on enhancing their own products, developing our initial concepts and creating new innovations.”